|
|
Volumn 5, Issue 5, 1996, Pages 469-494
|
|
Recombinant hirudin: A perspective
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ARGATROBAN;
DESULFATOHIRUDIN;
EFEGATRAN;
FIBRINOLYTIC AGENT;
GLYCOPROTEIN 2B INHIBITOR;
GLYCOPROTEIN 3A INHIBITOR;
HEPARIN;
HEPARINOID;
HIRUDIN;
HIRUGEN;
HIRULOG;
INOGATRAN;
IODINE 125;
LEPIRUDIN;
NAPSAGATRAN;
PEPTIDE DERIVATIVE;
PLASMIN;
PROSTAGLANDIN SYNTHASE INHIBITOR;
THROMBIN;
THROMBIN INHIBITOR;
TICLOPIDINE;
UNCLASSIFIED DRUG;
ANIMAL MODEL;
ANTICOAGULATION;
BIOTECHNOLOGY;
BLEEDING;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
COST;
DRUG INDICATION;
DRUG INDUSTRY;
DRUG MECHANISM;
DRUG RESEARCH;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LEECH;
MOLECULAR BIOLOGY;
NONHUMAN;
PHYSICAL CHEMISTRY;
REVIEW;
STROKE;
SUBCUTANEOUS DRUG ADMINISTRATION;
THROMBOSIS;
|
|
EID: 0030009915
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.5.5.469 Document Type: Review |
|
Times cited : (11)
|
|
References (0)
|
